Skip to main content
ONCOLYTICS BIOTECH INC logo

ONCOLYTICS BIOTECH INC — Investor Relations & Filings

Ticker · ONCY ISIN · CA6823108759 US Manufacturing
Filings indexed 1,036 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country US United States of America
Listing US ONCY

About ONCOLYTICS BIOTECH INC

https://www.oncolyticsbiotech.com/

Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company developing pelareorep, an intravenously delivered immuno-oncolytic virus. This immunotherapeutic agent is designed to selectively replicate in cancer cells, which triggers innate and adaptive anti-tumor immune responses. By awakening the patient's immune system, pelareorep aims to enhance the efficacy of other oncology treatments, such as chemotherapy and immune checkpoint inhibitors. The company's clinical development program is evaluating its potential across various cancer types, with a focus on HR+/HER2- breast cancer and pancreatic cancer, where it has demonstrated the potential to extend survival times and reduce tumor burden.

Recent filings

Filing Released Lang Actions
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Regulatory Filings
2026-05-04 English
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Regulatory Filings
2026-04-27 English
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Regulatory Filings
2026-04-06 English
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Regulatory Filings
2026-04-01 English
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Regulatory Filings
2026-03-20 English
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Regulatory Filings
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.